Screener / SEC EDGAR /CIK 0001551306 /10-K filed Feb 27, 2026, compared with Mar 3, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Health Services

Progyny, Inc. PGNY

Compare with peers Embed
Planned sales, announced before they happen

8 trading plans running, 29 Form 144 notices for $22.5M

10-Q, 10-K and Form 144
Plans running now 8 Geoffrey J Clapp, David Schlanger, Pete Anevski, Allison Swartz, Mark Livingston, Melissa Cummings
Plans adopted 18 reported since May 9, 2023 Form 144 notices 29 $22.5M the sellers expected to sell

What PGNY's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From Jun 10, 2025 to Oct 31, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.

InsiderWhatDateReported in
Geoffrey J Clapp
Chief Product Officer
Adopted 10b5-1 plan Aug 12, 2026 10-Q Nov 5, 2026
What the company wrote
On August 12, 2026, Geoffrey J Clapp, our Chief Product Officer, adopted a trading plan that is intended to satisfy the conditions under Rule 10b5-1(c) of the Exchange Act. Mr. Clapp’s trading plan is for the sale of up to 31,172 shares of the Company’s common stock in amounts and prices determined in accordance with a formula set forth in the plan. The plan terminates on the earlier of the date all shares under the plan are sold or June 30, 2027.
David Schlanger
Executive Chairman
Adopted 10b5-1 plan Jul 2, 2026 10-Q Nov 5, 2026
What the company wrote
On July 2, 2026, David Schlanger, our Executive Chairman, adopted a trading plan that is intended to satisfy the conditions under Rule 10b5-1(c) of the Exchange Act. Mr. Schlanger’s trading plan is for the sale of up to 1,300,000 shares of the Company’s common stock in amounts and prices determined in accordance with a formula set forth in the plan. The plan terminates on the earlier of the date all shares under the plan are sold or October 31, 2027.
David Schlanger
Executive Chairman
Adopted 10b5-1 plan Jul 2, 2026 10-Q Aug 7, 2026
What the company wrote
On July 2, 2026, David Schlanger, our Executive Chairman, adopted a trading plan that is intended to satisfy the conditions under Rule 10b5-1(c) of the Exchange Act. Mr. Schlanger’s trading plan is for the sale of up to 1,300,000 shares of the Company’s common stock in amounts and prices determined in accordance with a formula set forth in the plan. The plan terminates on the earlier of the date all shares under the plan are sold or October 31, 2027.
Pete Anevski
Chief Executive Officer
Adopted 10b5-1 plan Jul 2, 2026 10-Q Nov 5, 2026
What the company wrote
On July 2, 2026, Pete Anevski, our Chief Executive Officer, adopted a trading plan that is intended to satisfy the conditions under Rule 10b5-1(c) of the Exchange Act. Mr. Anevski’s trading plan is for the sale of up to 1,970,286 shares of the Company’s common stock in amounts and prices determined in accordance with a formula set forth in the plan and an additional indeterminate number of shares sold in eligible “sell-to-cover transactions” (as described in Rule 10b5-1(c)(1)(ii)(D)(3) under the Exchange Act) to satisfy tax withholding obligations arising exclusively from vesting of RSUs or PSUs. The number of shares subject to covered RSUs or PSUs that will be sold to satisfy applicable tax withholding obligations upon vesting is not currently determinable as the number will vary based on the market price of our common stock and the extent to which vesting conditions are satisfied. The plan terminates on the earlier of the date all shares under the plan are sold or October 31, 2027.
Pete Anevski
Chief Executive Officer
Adopted 10b5-1 plan Jul 2, 2026 10-Q Aug 7, 2026
What the company wrote
On July 2, 2026, Pete Anevski, our Chief Executive Officer, adopted a trading plan that is intended to satisfy the conditions under Rule 10b5-1(c) of the Exchange Act. Mr. Anevski’s trading plan is for the sale of up to 1,970,286 shares of the Company’s common stock in amounts and prices determined in accordance with a formula set forth in the plan and an additional indeterminate number of shares sold in eligible “sell-to-cover transactions” (as described in Rule 10b5-1(c)(1)(ii)(D)(3) under the Exchange Act) to satisfy tax withholding obligations arising exclusively from vesting of RSUs or PSUs. The number of shares subject to covered RSUs or PSUs that will be sold to satisfy applicable tax withholding obligations upon vesting is not currently determinable as the number will vary based on the market price of our common stock and the extent to which vesting conditions are satisfied. The plan terminates on the earlier of the date all shares under the plan are sold or October 31, 2027.
Allison Swartz
General Counsel and Secretary
Adopted 10b5-1 plan Jun 25, 2026 10-Q Aug 7, 2026
What the company wrote
On June 25, 2026, Allison Swartz, our General Counsel and Secretary, adopted a trading plan that is intended to satisfy the conditions under Rule 10b5-1(c) of the Exchange Act. Ms. Swartz’s trading plan is for the sale of up to 30,523 shares of the Company’s common stock in amounts and prices determined in accordance with a formula set forth in the plan. The plan terminates on the earlier of the date all shares under the plan are sold or June 24, 2027.
Mark Livingston
Chief Financial Officer
Adopted 10b5-1 plan May 28, 2026 10-Q Aug 7, 2026
What the company wrote
On May 28, 2026, Mark Livingston, our Chief Financial Officer, adopted a trading plan that is intended to satisfy the conditions under Rule 10b5-1(c) of the Exchange Act. Mr. Livingston’s trading plan is for the sale of up to 28,121 shares of the Company’s common stock in amounts and prices determined in accordance with a formula set forth in the plan. The plan terminates on the earlier of the date all shares under the plan are sold or May 28, 2027.
Peter Anevski
Chief Executive Officer
Ended 10b5-1 plan Jan 26, 2026 10-Q May 8, 2026
What the company wrote
On January 26, 2026, Peter Anevski, our Chief Executive Officer, terminated the trading plan that was intended to satisfy the conditions under Rule 10b5-1(c) of the Exchange Act adopted by him on March 31, 2025. The plan provided for the sale of up to 1,244,220 shares of the Company’s common stock in amounts and prices determined in accordance with a formula set forth in the plan.
Melissa Cummings
Chief Operating Officer
Adopted 10b5-1 plan Dec 19, 2025 10-K Feb 27, 2026
What the company wrote
On December 19, 2025, Melissa Cummings, our Chief Operating Officer, adopted a trading plan that is intended to satisfy the conditions under Rule 10b5-1(c) of the Exchange Act. Ms. Cummings' trading plan is for the sale of up to 24,062 shares of the Company's common stock in amounts and prices determined in accordance with a formula set forth in the plan. The plan terminates on the earlier of the date all shares under the plan are sold or March 31, 2027.
Mark Livingston
Chief Financial Officer
Adopted 10b5-1 plan Aug 15, 2025 10-Q Nov 7, 2025
What the company wrote
On August 15, 2025, Mark Livingston, our Chief Financial Officer, adopted a trading plan that is intended to satisfy the conditions under Rule 10b5-1(c) of the Exchange Act. Mr. Livingston’s trading plan is for the sale of up to 42,938 shares of the Company’s common stock in amounts and prices determined in accordance with a formula set forth in the plan. The plan terminates on the earlier of the date all shares under the plan are sold or August 14, 2026.
Cheryl Scott
director of the Company
Adopted 10b5-1 plan Jun 10, 2025 10-Q Aug 8, 2025
What the company wrote
On June 10, 2025, Cheryl Scott, a director of the Company, adopted a trading plan that is intended to satisfy the conditions under Rule 10b5-1(c) of the Exchange Act. Ms. Scott’s trading plan is for the sale of up to 6,689 shares of the Company’s common stock in amounts and prices determined in accordance with a formula set forth in the plan. The plan terminates on the earlier of the date all shares under the plan are sold or May 29, 2026.
Allison Swartz
General Counsel and Secretary
Adopted 10b5-1 plan May 13, 2025 10-Q Aug 8, 2025
What the company wrote
On May 13, 2025, Allison Swartz, our General Counsel and Secretary, adopted a trading plan that is intended to satisfy the conditions under Rule 10b5-1(c) of the Exchange Act. Ms. Swartz’s trading plan is for the sale of up to 28,126 shares of the Company’s common stock in amounts and prices determined in accordance with a formula set forth in the plan. The plan terminates on the earlier of the date all shares under the plan are sold or June 12, 2026.
Peter Anevski
Chief Executive Officer
Adopted 10b5-1 plan Mar 31, 2025 10-Q May 9, 2025
What the company wrote
On March 31, 2025, Peter Anevski, our Chief Executive Officer, adopted a trading plan that is intended to satisfy the conditions under Rule 10b5-1(c) of the Exchange Act. Mr. Anevski’s trading plan is for the sale of up to 1,244,220 shares of the Company’s common stock in amounts and prices determined in accordance with a formula set forth in the plan. The plan terminates on the earlier of the date all shares under the plan are sold or June 30, 2026.
Peter Anevski
Chief Executive Officer
Ended 10b5-1 plan Dec 20, 2024 10-K Mar 3, 2025
What the company wrote
On December 20, 2024, Peter Anevski, our Chief Executive Officer, terminated the trading plan that was intended to satisfy the conditions under Rule 10b5-1(c) of the Exchange Act adopted by him on January 26, 2024. The plan provided for the sale of up to 1,195,000 shares of the Company’s common stock in amounts and prices determined in accordance with a formula set forth in the plan.
Beth Seidenberg
director
Adopted 10b5-1 plan Jun 25, 2024 10-Q Aug 7, 2024
What the company wrote
On June 25, 2024, Beth Seidenberg, a director of the Company, adopted a trading plan that is intended to satisfy the conditions under Rule 10b5-1(c) of the Exchange Act. Ms. Seidenberg’s trading plan is for the sale of up to 283,999 shares of the Company’s common stock in amounts and prices determined in accordance with a formula set forth in the plan. The plan terminates on the earlier of the date all shares under the plan are sold or June 24, 2025.
Allison Swartz
General Counsel and Secretary
Adopted 10b5-1 plan May 14, 2024 10-Q Aug 7, 2024
What the company wrote
On May 14, 2024, Allison Swartz, our General Counsel and Secretary, adopted a trading plan that is intended to satisfy the conditions under Rule 10b5-1(c) of the Exchange Act. Ms. Swartz’s trading plan is for the sale of up to 17,241 shares of our common stock in amounts and prices determined in accordance with a formula set forth in the plan. The plan terminates on the earlier of the date all shares under the plan are sold or May 14, 2025.
Peter Anevski
Chief Executive Officer
Adopted 10b5-1 plan Jan 26, 2024 10-Q May 10, 2024
What the company wrote
On January 26, 2024, Peter Anevski, our Chief Executive Officer, adopted a trading plan that is intended to satisfy the conditions under Rule 10b5-1(c) of the Exchange Act. Mr. Anevski’s trading plan is for the sale of up to 1,195,000 shares of the Company’s common stock in amounts and prices determined in accordance with a formula set forth in the plan. The plan terminates on the earlier of the date all shares under the plan are sold or April 30, 2025.
Michael Sturmer
President
Adopted 10b5-1 plan Aug 31, 2023 10-Q Nov 8, 2023
What the company wrote
On August 31, 2023, Michael Sturmer, our President, adopted a trading plan that is intended to satisfy the conditions under Rule 10b5-1(c) of the Exchange Act. Mr. Sturmer's trading plan is for the sale of up to approximately 176,880 shares of the Company's common stock, including upon the vesting and settlement of certain equity awards, in amounts and prices determined in accordance with a formula set forth in the plan. Because the aggregate number of shares that may be sold under the Mr. Sturmer's plan will be net of shares withheld by the Company to satisfy Mr. Sturmer's tax obligations upon the vesting and settlement of certain equity awards, the precise number of shares that may be sold under Mr. Sturmer's trading plan is not yet determinable. The plan terminates on the earlier of the date all shares under the plan are sold or August 23, 2024.
Mark Livingston
Chief Financial Officer
Adopted 10b5-1 plan Aug 7, 2023 10-Q Nov 8, 2023
What the company wrote
On August 7, 2023, Mark Livingston, our Chief Financial Officer, adopted a trading plan that is intended to satisfy the conditions under Rule 10b5-1(c) of the Exchange Act. Mr. Livingston's trading plan is for the sale of up to 148,627 shares of the Company's common stock in amounts and prices determined in accordance with a formula set forth in the plan and terminates on the earlier of the date all shares under the plan are sold or April 30, 2024.
David Schlanger
Executive Chairman
Adopted 10b5-1 plan Jun 23, 2023 10-Q Nov 8, 2023
What the company wrote
On June 23, 2023, David Schlanger, our Executive Chairman, adopted a trading plan that is intended to satisfy the conditions under Rule 10b5-1(c) of the Exchange Act. Mr. Schlanger's trading plan is for the sale of up to 960,000 shares of the Company's common stock in amounts and prices determined in accordance with a formula set forth in the plan and terminates on the earlier of the date all shares under the plan are sold or August 30, 2024.
Show the other 12 plans

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 9, 2023.

Notices of planned sales

Form 144 · Form 144 XML, SEC

What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).

FiledSellerSharesValue
Nov 12, 2026 Clapp Geoffrey
Officer
774 $28K
Nov 10, 2026 ANEVSKI 2026 SOUTH DAKOTA NGCG TR
Director, Officer
50,139 $1.8M
Nov 5, 2026 DAVID SCHLANGER
Director, Officer
200,000 $6.0M
Nov 5, 2026 ANEVSKI 2026 SOUTH DAKOTA NGCG TR
Director, Officer
90,000 $2.7M
Nov 5, 2026 PETER ANEVSKI
Director, Officer
314,738 $9.5M
Nov 4, 2026 Livingston Mark S.
Officer
2,139 $64K
Oct 14, 2026 Cummings Melissa B
Officer
1,879 $53K
Sep 23, 2026 Swartz Allison
Officer
3,903 $102K
Sep 10, 2026 GORDON KEVIN K
Director
11,500 $312K
Jul 14, 2026 Cummings Melissa B
Officer
2,244 $71K
Jun 4, 2026 Livingston Mark S.
Officer
2,517 $64K
Jun 4, 2026 Swartz Allison
Officer
599 $15K
Jun 3, 2026 Swartz Allison
Officer
1,199 $30K
Jun 2, 2026 Clapp Geoffrey
Officer
1,530 $39K
Jun 2, 2026 Livingston Mark S.
Officer
279 $7K
Jun 1, 2026 Scott Cheryl
Director
7,439 $196K
May 28, 2026 Swartz Allison
Officer
2,398 $61K
May 27, 2026 GORDON KEVIN K
Director
5,500 $137K
May 22, 2026 Scott Cheryl
Director
2,676 $66K
May 20, 2026 Livingston Mark S.
Officer
8,275 $211K
May 19, 2026 Cummings Melissa B
Officer
9,578 $239K
Mar 4, 2026 Swartz Allison
Officer
599 $11K
Mar 3, 2026 Swartz Allison
Officer
4,657 $81K
Mar 2, 2026 Swartz Allison
Officer
2,199 $38K
Dec 11, 2025 Livingston Mark S.
Officer
459 $12K
Dec 4, 2025 Swartz Allison
Officer
530 $13K
Dec 2, 2025 Livingston Mark S.
Officer
213 $5K
Nov 28, 2025 Swartz Allison
Officer
2,398 $64K
Nov 17, 2025 Livingston Mark S.
Officer
21,303 $543K
Show the other 21 notices

From the Form 144 XML filed with the SEC, since Nov 17, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/PGNY/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.